So the fate of our leronlimab is now in the hands of Cavazzoni and her likes who are "commonly later given jobs at the companies whose drugs they helped approve" and disapprove those drugs which present danger to the companies' profits.
_________________

FDA article that might be of interest...

https://www.forbes.com/sites/davidgortler/202...eadership/

Read More: https://investorshangout.com/post/newpost/605...z71sr4J7yg